Clinical Trial

Developing Interventions for Protecting HIV-Exposed Uninfected Infants Against Severe Infections

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Research has shown that babies who are exposed to HIV, but are uninfected (negative HIV status), have a bigger risk of developing severe infections. There are naturally occurring organisms in the gut that may determine how the body protects itself against infections. These organisms may be different in babies who were exposed to the HIV virus in utero, compared to those who were not exposed. This study wants to see if the organisms in the gut of babies can be modified by supplementing the diet of the pregnant mother or of the baby at 6 months of age with Inkomasi (pasteurized fermented milk). The study will compare the type and amount of organisms in those who received supplementation and those who did not receive supplementation.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-26; most recent amendment 2026-05-13.
Trial Details
NCT Number NCT07052409
Lead Sponsor University of Colorado, Denver
Conditions Gut Microbiome
Enrollment 72 participants
Start Date 2025-04-10
Primary Completion 2028-06 (estimated)
Study Completion 2029-07 (estimated)
Updated on ClinicalTrials.gov 2026-05-15